NEURONETICS, INC.13G

Company

Neuronetics, Inc.

Filed

February 14, 2020

Accession Number

0000905718-20-000229

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →